Pharmaceutics_R&D
3.9K views | +0 today
Follow
Pharmaceutics_R&D
Pharmaceutical companies R&D specifically in neuroscience, CNS disease, pain and electrophysiology
Your new post is loading...
Your new post is loading...
Scooped by Julien Hering, PhD
Scoop.it!

Roche Bets On Early-Stage Alzheimer’s: Luca Explains

Roche Bets On Early-Stage Alzheimer’s: Luca Explains | Pharmaceutics_R&D | Scoop.it
In recent months, Alzheimer’s compounds have been hot news. Pfizer and Johnson & Johnson had one that flopped. Eli Lilly released mixed study results that generated a mix of hype and hope. And Merck (back stories here, here and here). And Merck is betting on one in a test with patients suffering mild to moderate symptoms. Meanwhile, another big drugmaker, Roche, is chugging along with a few compounds of its own and hopes its focus on early-stage disease will prove correct. We spoke briefly with Luca Santarelli, the head of neuroscience at Roche, about its efforts… (...) - Pharmalot, By Ed Silverman, December 11th, 2012
more...
No comment yet.
Scooped by Julien Hering, PhD
Scoop.it!

Genentech's Alzheimer's antibody trial to study disease prevention

Genentech's Alzheimer's antibody trial to study disease prevention | Pharmaceutics_R&D | Scoop.it

The first clinical trial of a drug's ability to forestall Alzheimer's disease in cognitively healthy individuals is preparing to launch. Genentech of S. San Francisco, California, the Banner Alzheimer's Institute in Phoenix,…- by Ken GarberNature Biotechnology 30, 731–732, 7 August 2012

more...
No comment yet.